Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HC-58 in Severe Upper Limb Hemiplegia After Stroke
NCT01623622Phase 2Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Jul 2012
- Primary completion
- May 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of elcatonin in complex regional pain syndrome type I (CRPS), sponsored by Asahi Kasei Corporation. Started Jul 2012; status: completed.
02
Drugs
elcatonin
03
Conditions
complex regional pain syndrome type I (CRPS)
Beyond the preview
Go deeper on NCT01623622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623622.